• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

安非他酮在配体门控离子通道中结合位点的鉴定。

Identification of a binding site for bupropion in ligand-gated ion channel.

作者信息

Pirayesh Elham, Do Hoa Quynh, Ferreira Garren, Pandhare Akash, Gallardo Zackary Ryan, Jansen Michaela

机构信息

Medical Student Summer Research Program, School of Medicine, Texas Tech University Health Sciences Center, Lubbock, TX, 79430 USA.

出版信息

bioRxiv. 2023 Oct 10:2023.10.09.561596. doi: 10.1101/2023.10.09.561596.

DOI:10.1101/2023.10.09.561596
PMID:37873398
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10592773/
Abstract

Bupropion is an atypical antidepressant and smoking cessation drug which causes adverse effects such as insomnia, irritability, and anxiety. Bupropion inhibits dopamine and norepinephrine reuptake transporters and eukaryotic cation-conducting pentameric ligand-gated ion channels (pLGICs), such as nicotinic acetylcholine (nACh) and serotonin type 3A (5-HT3A) receptors, at clinically relevant concentrations. However, the binding sites and binding mechanisms of bupropion are still elusive. To further understand the inhibition of pLGICs by bupropion, in this work, using a prokaryotic homologue of pLGICs as a model, we examined the inhibitory potency of bupropion in ligand-gated ion channel (GLIC), a proton-gated ion channel. Bupropion inhibited proton-induced currents in GLIC with an inhibitory potency of 14.9 ± 2.0 μM, comparable to clinically attainable concentrations previously shown to also modulate eukaryotic pLGICs. Using single amino acid substitutions in GLIC and two-electrode voltage-clamp recordings, we further determined a binding site for bupropion in the lower third of the first transmembrane segment M1 at residue T214. The sidechain of M1 T214 together with additional residues of M1 and also of M3 of the adjacent subunit have previously been shown to contribute to binding of other lipophilic molecules like allopregnanolone and pregnanolone.

摘要

安非他酮是一种非典型抗抑郁药和戒烟药物,会引起失眠、易怒和焦虑等不良反应。在临床相关浓度下,安非他酮会抑制多巴胺和去甲肾上腺素再摄取转运体以及真核阳离子传导五聚体配体门控离子通道(pLGICs),如烟碱型乙酰胆碱(nACh)和5-羟色胺3A(5-HT3A)受体。然而,安非他酮的结合位点和结合机制仍不清楚。为了进一步了解安非他酮对pLGICs的抑制作用,在这项研究中,我们以pLGICs的原核同源物为模型,检测了安非他酮对质子门控离子通道配体门控离子通道(GLIC)的抑制效力。安非他酮抑制GLIC中质子诱导的电流,抑制效力为14.9±2.0μM,与先前显示可调节真核pLGICs的临床可达到浓度相当。通过在GLIC中进行单氨基酸替换和双电极电压钳记录,我们进一步确定了安非他酮在第一个跨膜片段M1的下三分之一处T214残基的结合位点。先前已证明,M1 T214的侧链以及M1的其他残基以及相邻亚基的M3残基有助于结合其他亲脂性分子,如别孕烯醇酮和孕烷醇酮。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9258/10592773/312c86c5540d/nihpp-2023.10.09.561596v1-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9258/10592773/bd3aa2ace6b2/nihpp-2023.10.09.561596v1-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9258/10592773/c8ca6e0e1f01/nihpp-2023.10.09.561596v1-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9258/10592773/6a09f30c38c3/nihpp-2023.10.09.561596v1-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9258/10592773/f8a73cda30cb/nihpp-2023.10.09.561596v1-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9258/10592773/312c86c5540d/nihpp-2023.10.09.561596v1-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9258/10592773/bd3aa2ace6b2/nihpp-2023.10.09.561596v1-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9258/10592773/c8ca6e0e1f01/nihpp-2023.10.09.561596v1-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9258/10592773/6a09f30c38c3/nihpp-2023.10.09.561596v1-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9258/10592773/f8a73cda30cb/nihpp-2023.10.09.561596v1-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9258/10592773/312c86c5540d/nihpp-2023.10.09.561596v1-f0005.jpg

相似文献

1
Identification of a binding site for bupropion in ligand-gated ion channel.安非他酮在配体门控离子通道中结合位点的鉴定。
bioRxiv. 2023 Oct 10:2023.10.09.561596. doi: 10.1101/2023.10.09.561596.
2
A bupropion modulatory site in the Gloeobacter violaceus ligand-gated ion channel.蓝细菌紫膜配体门控离子通道中的安非他酮调节位点。
Biophys J. 2024 Jul 16;123(14):2185-2198. doi: 10.1016/j.bpj.2024.04.027. Epub 2024 Apr 27.
3
The antidepressant bupropion is a negative allosteric modulator of serotonin type 3A receptors.抗抑郁药安非他酮是5-羟色胺3A受体的负性变构调节剂。
Neuropharmacology. 2017 Feb;113(Pt A):89-99. doi: 10.1016/j.neuropharm.2016.09.021. Epub 2016 Sep 24.
4
Bupropion Inhibits Serotonin Type 3AB Heteromeric Channels at Clinically Relevant Concentrations.安非他酮以临床相关浓度抑制 5-羟色胺 3AB 异源四聚体通道。
Mol Pharmacol. 2020 Mar;97(3):171-179. doi: 10.1124/mol.119.118349. Epub 2019 Dec 23.
5
Direct interaction of the resistance to inhibitors of cholinesterase type 3 protein with the serotonin receptor type 3A intracellular domain.3型胆碱酯酶抑制剂抗性蛋白与3A型5-羟色胺受体细胞内区域的直接相互作用。
J Neurochem. 2016 May;137(4):528-38. doi: 10.1111/jnc.13578. Epub 2016 Mar 11.
6
Functional Chimeras of GLIC Obtained by Adding the Intracellular Domain of Anion- and Cation-Conducting Cys-Loop Receptors.通过添加阴离子和阳离子传导性半胱氨酸环受体的细胞内结构域获得的GLIC功能性嵌合体。
Biochemistry. 2015 Apr 28;54(16):2670-2682. doi: 10.1021/acs.biochem.5b00203. Epub 2015 Apr 17.
7
Photoaffinity labeling the propofol binding site in GLIC.荧光标记法在 GLIC 中标记丙泊酚结合位点。
Biochemistry. 2014 Jan 14;53(1):135-42. doi: 10.1021/bi401492k. Epub 2013 Dec 30.
8
Propofol binding to the resting state of the gloeobacter violaceus ligand-gated ion channel (GLIC) induces structural changes in the inter- and intrasubunit transmembrane domain (TMD) cavities.依托于紫细菌中的配体门控离子通道(GLIC)的静息状态,依托咪酯与通道蛋白结合,诱导了跨膜结构域(TMD)腔的亚基间和亚基内的构象变化。
J Biol Chem. 2013 Jun 14;288(24):17420-31. doi: 10.1074/jbc.M113.464040. Epub 2013 May 2.
9
Macroscopic kinetics of pentameric ligand gated ion channels: comparisons between two prokaryotic channels and one eukaryotic channel.五聚体配体门控离子通道的宏观动力学:两种原核通道和一种真核通道的比较。
PLoS One. 2013 Nov 19;8(11):e80322. doi: 10.1371/journal.pone.0080322. eCollection 2013.
10
Multisite binding of a general anesthetic to the prokaryotic pentameric Erwinia chrysanthemi ligand-gated ion channel (ELIC).普遍麻醉剂与原核五聚体菊欧文氏菌配体门控离子通道(ELIC)的多位点结合。
J Biol Chem. 2013 Mar 22;288(12):8355-8364. doi: 10.1074/jbc.M112.424507. Epub 2013 Jan 30.

本文引用的文献

1
Allopregnanolone-mediated GABAA-Rα4 function in amygdala and hippocampus of PMDD liver qi-invasion syndrome model rats.经前期综合征肝气郁结证模型大鼠杏仁核和海马中 Allopregnanolone 介导的 GABAA-Rα4 功能。
Aging (Albany NY). 2023 Feb 23;15(4):1143-1157. doi: 10.18632/aging.204541.
2
Structural mechanisms of GABA receptor autoimmune encephalitis.GABA 受体自身免疫性脑炎的结构机制。
Cell. 2022 Jul 7;185(14):2469-2477.e13. doi: 10.1016/j.cell.2022.06.025.
3
Use of Bupropion in the Management of Negative Symptom Schizophrenia: A Case Series.
安非他酮用于阴性症状型精神分裂症治疗:病例系列
Cureus. 2022 Mar 26;14(3):e23518. doi: 10.7759/cureus.23518. eCollection 2022 Mar.
4
Shared structural mechanisms of general anaesthetics and benzodiazepines.全麻药物和苯二氮䓬类药物的共同结构机制。
Nature. 2020 Sep;585(7824):303-308. doi: 10.1038/s41586-020-2654-5. Epub 2020 Sep 2.
5
An Evolving Therapeutic Rationale for Targeting the α Nicotinic Acetylcholine Receptor in Autism Spectrum Disorder.针对自闭症谱系障碍中α烟碱型乙酰胆碱受体的不断发展的治疗原理
Curr Top Behav Neurosci. 2020;45:167-208. doi: 10.1007/7854_2020_136.
6
Bupropion Inhibits Serotonin Type 3AB Heteromeric Channels at Clinically Relevant Concentrations.安非他酮以临床相关浓度抑制 5-羟色胺 3AB 异源四聚体通道。
Mol Pharmacol. 2020 Mar;97(3):171-179. doi: 10.1124/mol.119.118349. Epub 2019 Dec 23.
7
Single-Agent Bupropion Exposures: Clinical Characteristics and an Atypical Cause of Serotonin Toxicity.单药安非他酮暴露:临床特征和非典型的 5-羟色胺毒性原因。
J Med Toxicol. 2020 Jan;16(1):12-16. doi: 10.1007/s13181-019-00749-4. Epub 2019 Dec 10.
8
5-HT Receptor Antagonists in Neurologic and Neuropsychiatric Disorders: The Iceberg Still Lies beneath the Surface.5-羟色胺受体拮抗剂在神经和神经精神疾病中的应用:冰山仍在水面之下。
Pharmacol Rev. 2019 Jul;71(3):383-412. doi: 10.1124/pr.118.015487.
9
Pharmacokinetic and pharmacodynamic of bupropion: integrative overview of relevant clinical and forensic aspects.丁丙诺啡的药代动力学和药效学:相关临床和法医方面的综合概述。
Drug Metab Rev. 2019 Aug;51(3):293-313. doi: 10.1080/03602532.2019.1620763. Epub 2019 Jun 14.
10
GABA receptor signalling mechanisms revealed by structural pharmacology.结构药理学揭示的 GABA 受体信号转导机制。
Nature. 2019 Jan;565(7740):454-459. doi: 10.1038/s41586-018-0832-5. Epub 2019 Jan 2.